| Method of Modulating the Basal Metabolic Rate of a Dieting Mammal by Administration of a Metabolic Modulating Agent to the Dieting Mammal |
7-KETO® Use |
United States |
7199116 |
| Immunoglobulin Variants |
AggreSolve™ Screening Technology |
Japan |
5901522 |
| Immunoglobulin Variants |
AggreSolve™ Screening Technology |
United States |
8951516 |
| Immunoglobulin Variants |
AggreSolve™ Screening Technology |
United States |
9290563 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
China |
ZL201880047848.6 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
France |
3619188 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
Germany |
3619188 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
Hong Kong |
40019698 B |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
Japan |
6737967 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
Switzerland |
3619188 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
United Kingdom |
3619188 |
| Method For Preparation Of 5-Fluoro-2-Methyl-3-Nitrobenzoic Acid And Its Methyl Ester |
API Manufacturing Methods |
United States |
11001552 |
| Method For Preparation Of Alpha-Methyl-L-Proline |
API Manufacturing Methods |
China |
ZL201880042883.9 |
| Method For Preparation Of Alpha-Methyl-L-Proline |
API Manufacturing Methods |
Hong Kong |
40017759B |
| Method For Preparation Of Carsalam |
API Manufacturing Methods |
Israel |
287941 |
| Method For Preparation Of Carsalam |
API Manufacturing Methods |
Japan |
7105386 |
| Method For Preparation Of Difluoromethylornithine |
API Manufacturing Methods |
France |
3634943 |
| Method For Preparation Of Difluoromethylornithine |
API Manufacturing Methods |
Germany |
3634943 |
| Method For Preparation Of Difluoromethylornithine |
API Manufacturing Methods |
Japan |
6781858 |
| Method For Preparation Of Difluoromethylornithine |
API Manufacturing Methods |
Switzerland |
3634943 |
| Method For Preparation Of Difluoromethylornithine |
API Manufacturing Methods |
United Kingdom |
3634943 |
| Method For Preparation Of N-Carboxyanhydrides |
API Manufacturing Methods |
France |
3810579 |
| Method For Preparation Of N-Carboxyanhydrides |
API Manufacturing Methods |
Germany |
3810579 |
| Method For Preparation Of N-Carboxyanhydrides |
API Manufacturing Methods |
Japan |
7042969 |
| Method For Preparation Of N-Carboxyanhydrides |
API Manufacturing Methods |
Switzerland |
3810579 |
| Method For Preparation Of N-Carboxyanhydrides |
API Manufacturing Methods |
United Kingdom |
3810579 |
| Composition Comprising Arabinogalactan and Polyphenols from Larch Trees |
Arabinogalactan Composition Use |
Australia |
2013231673 |
| Composition Comprising Arabinogalactan and Polyphenols from Larch Trees |
Arabinogalactan Composition Use |
Japan |
6490662 |
| Composition Comprising Arabinogalactan and Polyphenols from Larch Trees |
Arabinogalactan Composition Use |
Singapore |
10201707481S |
| Composition Comprising Arabinogalactan and Polyphenols from Larch Trees |
Arabinogalactan Composition Use |
United States |
9393259 |
| Arabinogalactan for Enhancing the Adaptive Immune Response |
Arabinogalactan Use |
United States |
8784844 |
| Pharmaceutical Compositions Of Amorphous Dispersions Of Drugs And Lipophilic Microphase-Forming Materials |
ASD Compositions |
United States |
9486410 |
| Pharmaceutical Compositions With Enhanced Performance |
ASD Compositions |
United States |
8940800 |
| Solid Dispersion Comprising A Poorly Water Soluble Drug |
ASD Compositions |
France |
2101741 |
| Solid Dispersion Comprising A Poorly Water Soluble Drug |
ASD Compositions |
Germany |
602007008470.9 |
| Solid Dispersion Comprising A Poorly Water Soluble Drug |
ASD Compositions |
Ireland |
2101741 |
| Solid Dispersion Comprising A Poorly Water Soluble Drug |
ASD Compositions |
United Kingdom |
2101741 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
Belgium |
2956121 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
France |
2956121 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
Germany |
602014026156.6 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
Japan |
6396333 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
United Kingdom |
2956121 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
United States |
9737538 |
| Solid Dispersions Of Low-Water Solubility Actives |
ASD Compositions |
United States |
10322126 |
| Spray Dried Formulation |
ASD Compositions |
United States |
8372836 |
| Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs |
Poloxamers And Stabilizing Polymers |
ASD Compositions |
France |
1701703 |
|
|
| Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs |
Poloxamers And Stabilizing Polymers |
ASD Compositions |
Germany |
602004031767.5 |
|
|
| Stabilized Pharmaceutical Solid Compositions Of Low-Solubility Drugs |
Poloxamers And Stabilizing Polymers |
ASD Compositions |
United Kingdom |
1701703 |
|
|
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Belgium |
3167880 |
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
France |
3167880 |
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Germany |
3167880 |
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Japan |
6768060 |
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
United Kingdom |
3167880 |
| Acid Resistant Banding Or Sealing Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
United States |
11246837 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Belgium |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Czech Republic |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
France |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Germany |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Italy |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Japan |
6219836 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Japan |
6836977 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Netherlands |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
Spain |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
United Kingdom |
2776016 |
| Acid Resistant Banding Solution For Acid Resistant Two Piece Hard Capsules |
Capsule - Banding |
United States |
9980918 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Belgium |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Canada |
2873837 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
France |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Germany |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Italy |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Japan |
6306573 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Japan |
6598841 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Netherlands |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
Spain |
2852412 |
| Acid Resistant Banding Solution for Two Piece Hard Capsules |
Capsule - Banding |
United Kingdom |
2852412 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Belgium |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
France |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Germany |
602006041222.3 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Italy |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Japan |
5522937 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Netherlands |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
Spain |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (Hpmc) As A Base |
Capsule - Banding |
United Kingdom |
1942878 |
| Method For Banding Hard Capsules Using Hydroxypropylmethyl Cellulose (HPMC) As A Base |
Capsule - Banding |
United States |
9579290 |
| Capsule Formulation |
Capsule - Fill Formulations |
Japan |
6588193 |
| Capsule Formulation Comprising Bifidobacterium Bacteria and the Production Method Thereof |
Capsule - Fill Formulations |
Japan |
6297441 |
| Curcumin Solid Lipid Particles and Methods for their Preparation and Use |
Capsule - Fill Formulations |
Belgium |
2964243 |
| Curcumin Solid Lipid Particles and Methods for their Preparation and Use |
Capsule - Fill Formulations |
France |
2964243 |
| Curcumin Solid Lipid Particles and Methods for their Preparation and Use |
Capsule - Fill Formulations |
Germany |
2964243 |
| Curcumin Solid Lipid Particles and Methods for their Preparation and Use |
Capsule - Fill Formulations |
United Kingdom |
2964243 |
| Curcumin Solid Lipid Particles and Methods for their Preparation and Use |
Capsule - Fill Formulations |
United States |
10166187 |
| Delivery Carrier |
Capsule - Fill Formulations |
France |
2498760 |
| Delivery Carrier |
Capsule - Fill Formulations |
Germany |
602010025605.7 |
| Delivery Carrier |
Capsule - Fill Formulations |
United Kingdom |
2498760 |
| Delivery Carrier |
Capsule - Fill Formulations |
United States |
9333177 |
| Hard Capsule Formulation |
Capsule - Fill Formulations |
Brazil |
BR112015020307-8 |
| Hard Capsule Formulation |
Capsule - Fill Formulations |
Japan |
6420261 |
| Hard Capsule Formulation |
Capsule - Fill Formulations |
Japan |
6856601 |
| Hard Capsule Formulation |
Capsule - Fill Formulations |
United States |
10172803 |
| Liquid Filled Delivery System |
Capsule - Fill Formulations |
United States |
8795720 |
| Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid |
Capsule - Fill Formulations |
United States |
10188611 |
| Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) |
Capsule - Fill Formulations |
Belgium |
3082778 |
| Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) |
Capsule - Fill Formulations |
France |
3082778 |
| Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) |
Capsule - Fill Formulations |
Germany |
3082778 |
| Stable Liquid Filled Hard Capsule Comprising Beta-Hydroxy-Beta Methylbutyric Acid (HMB) |
Capsule - Fill Formulations |
United Kingdom |
3082778 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Belgium |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Belgium |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Belgium |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Belgium |
3715837 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
China |
ZL201180059062.4 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
France |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
France |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
France |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
France |
3715837 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Germany |
602011021060.2 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Germany |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Germany |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Germany |
3715837 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Italy |
3021108 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Italy |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Italy |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Italy |
3715837 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Japan |
6000260 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Netherlands |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Netherlands |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Netherlands |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Netherlands |
3715837 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Spain |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Spain |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Spain |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
Spain |
3715837 |
| Apparatus and Method for Acquiring a Two-Dimensional Image of the Surface of a Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2625509 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United Kingdom |
3021108 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United Kingdom |
3709007 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United Kingdom |
3715837 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United States |
9414027 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United States |
9575011 |
| Apparatus And Method For Acquiring A Two-Dimensional Image Of The Surface Of A Three-Dimensional Object |
Capsule Manufacturing Process & Equipment |
United States |
10113977 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
Belgium |
2049313 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
Canada |
2660041 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
France |
2049313 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
Germany |
602007043597.8 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
Japan |
5128596 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
Mexico |
298203 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2049313 |
| Apparatus And Method For Removing Molded Articles From Their Molds |
Capsule Manufacturing Process & Equipment |
United States |
8398912 |
| Apparatus for and Method of Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Germany |
602004027364.3 |
| Apparatus for and Method of Sealing Capsules |
Capsule Manufacturing Process & Equipment |
United Kingdom |
1617800 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
Belgium |
2358328 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
France |
2358328 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
Japan |
5642081 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
Mexico |
316978 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2358328 |
| Apparatus For Handling Capsules And Capsule Processing Equipment Including Such An Apparatus |
Capsule Manufacturing Process & Equipment |
United States |
8646591 |
| Apparatus for Sealing a Pharmaceutically Acceptable Hard Shell Capsule |
Capsule Manufacturing Process & Equipment |
United States |
8491298 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Belgium |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
France |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Germany |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Italy |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Japan |
6895984 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Netherlands |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
Spain |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
United Kingdom |
3219300 |
| Aseptic Hard Capsule Sealing Apparatus And Methods |
Capsule Manufacturing Process & Equipment |
United States |
10751255 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
Belgium |
2185817 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
France |
2185817 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
Germany |
602008050408.5 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
Italy |
2185817 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
Japan |
5452488 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
Mexico |
324362 |
| Liquid Pump |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2185817 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Belgium |
2049064 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Brazil |
PI0715125-0 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Canada |
2660037 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
China |
ZL200780029122.1 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
France |
2049064 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Germany |
602007009693.6 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Italy |
2049064 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Japan |
5197596 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Mexico |
291834 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
Spain |
2049064 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2049064 |
| Method and Apparatus for Sealing Capsules |
Capsule Manufacturing Process & Equipment |
United States |
8181425 |
| Method of Sealing a Hard Shell Capsule |
Capsule Manufacturing Process & Equipment |
United States |
7645407 |
| Sealing Clamp for Capsule Sealing + |
Capsule Manufacturing Process & Equipment |
Mexico |
265293 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Belgium |
2457551 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
France |
2457551 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
France |
2083787 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Germany |
602007040166.6 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Germany |
602007027363.3 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Italy |
2457551 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Mexico |
301695 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
Spain |
2457551 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
United Kingdom |
2457551 |
| Transfer Line |
Capsule Manufacturing Process & Equipment |
United States |
8671650 |
| Process for Making Pullulan |
Capsule Material (Pullulan) |
Japan |
7222911 |
| Process for Making Pullulan |
Capsule Material (Pullulan) |
United States |
11319566 |
| Capsule Comprising A Print Or Label (Dotted Lines) |
Capsules |
EUIPO |
003108505-0001 |
| Capsule Comprising A Print Or Label (Dotted Lines) |
Capsules |
EUIPO |
003108505-0002 |
| Colloidal Dispersion Comprising HPMCAS |
Capsules |
United States |
10471152 |
| Dosage Form Articles |
Capsules |
Belgium |
3076954 |
| Dosage Form Articles |
Capsules |
France |
3076954 |
| Dosage Form Articles |
Capsules |
Germany |
3076954 |
| Dosage Form Articles |
Capsules |
United Kingdom |
3076954 |
| Dosage Form Articles |
Capsules |
United States |
9980905 |
| Dosage Form Articles for Delayed Release |
Capsules |
Belgium |
3028694 |
| Dosage Form Articles for Delayed Release |
Capsules |
France |
3028694 |
| Dosage Form Articles for Delayed Release |
Capsules |
Germany |
602014011687 |
| Dosage Form Articles for Delayed Release |
Capsules |
United Kingdom |
3028694 |
| Dosage Form Articles for Delayed Release |
Capsules |
United States |
10555908 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Belgium |
2777802 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Belgium |
3077086 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Canada |
2932562 |
| Multi-Compartment Dosage Form Articles |
Capsules |
France |
2777802 |
| Multi-Compartment Dosage Form Articles |
Capsules |
France |
3077086 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Germany |
602013005497.5 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Germany |
602014018609.2 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Japan |
6082850 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Netherlands |
2777802 |
| Multi-Compartment Dosage Form Articles |
Capsules |
Netherlands |
3077086 |
| Multi-Compartment Dosage Form Articles |
Capsules |
United Kingdom |
2777802 |
| Multi-Compartment Dosage Form Articles |
Capsules |
United Kingdom |
3077086 |
| Multi-Compartment Dosage Form Articles |
Capsules |
United States |
9561189 |
| Multi-Compartmented Container |
Capsules |
Belgium |
2211820 |
| Multi-Compartmented Container |
Capsules |
France |
2211820 |
| Multi-Compartmented Container |
Capsules |
Germany |
602008015434.3 |
| Multi-Compartmented Container |
Capsules |
Japan |
5667874 |
| Multi-Compartmented Container |
Capsules |
United Kingdom |
2211820 |
| Multi-Compartmented Container |
Capsules |
United States |
8968717 |
| Multi-Compartmented Container |
Capsules |
United States |
9456990 |
| Print or Label for a Capsule Surface (Vertical) |
Capsules |
EUIPO |
003107515-0001 |
| Print or Label for a Capsule Surface (Vertical) |
Capsules |
EUIPO |
003107515-0002 |
| Separable Capsule |
Capsules |
Canada |
2900305 |
| Separable Capsule |
Capsules |
Japan |
6436977 |
| Separable Capsule |
Capsules |
United States |
9775813 |
| Separable Capsule |
Capsules |
United States |
10568838 |
| Separable Capsule For Sprinkling Applications |
Capsules |
United States |
10610490 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0001 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0002 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0003 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0004 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0005 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0006 |
| Sprinkle Design |
Capsules |
EUIPO |
002542522-0007 |
| Tamperproof Oral Dosage Form |
Capsules |
Japan |
6905512 |
| Tamperproof Oral Dosage Form |
Capsules |
Japan |
6905513 |
| Tamperproof Oral Dosage Form |
Capsules |
United States |
10709640 |
| Tamperproof Oral Dosage Form |
Capsules |
United States |
10470975 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Belgium |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
France |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Germany |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Italy |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Netherlands |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Spain |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
Switzerland |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
United Kingdom |
3199148 |
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
United States |
10 |
603 |
286 |
|
| Compositions And Resulting Hard Capsules Comprising Hydrophilic Coloring Foodstuff Concentrates |
Capsules - Color |
United States |
11406601 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Austria |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Belgium |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Brazil |
112012006651-0 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Canada |
2775227 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
China |
ZL201080042764.7 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Czech Republic |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Denmark |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
France |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Germany |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
India |
342484 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Italy |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Japan |
5777625 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Korea - South |
10-1762460 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Mexico |
334274 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Netherlands |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Poland |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
Spain |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
United Kingdom |
2480218 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
United States |
8852631 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
United States |
9700517 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
United States |
10231934 |
| Acid Resistant Capsules |
Capsules - DRcaps® capsules |
United States |
10874619 |
| Gelatin Capsules And Gelatin Compositions For Forming Capsule Coating |
Capsules - Gelatin |
Japan |
5766205 |
| Container |
Capsules - Licaps® capsules |
Belgium |
1915121 |
| Container |
Capsules - Licaps® capsules |
Brazil |
PI 0614735-6 |
| Container |
Capsules - Licaps® capsules |
Canada |
2617967 |
| Container |
Capsules - Licaps® capsules |
China |
ZL201210011817.X |
| Container |
Capsules - Licaps® capsules |
France |
1915121 |
| Container |
Capsules - Licaps® capsules |
Germany |
602006038698.2 |
| Container |
Capsules - Licaps® capsules |
India |
272531 |
| Container |
Capsules - Licaps® capsules |
Italy |
1915121 |
| Container |
Capsules - Licaps® capsules |
Japan |
4422779 |
| Container |
Capsules - Licaps® capsules |
Japan |
5006913 |
| Container |
Capsules - Licaps® capsules |
Mexico |
309351 |
| Container |
Capsules - Licaps® capsules |
Netherlands |
1915121 |
| Container |
Capsules - Licaps® capsules |
Spain |
1915121 |
| Container |
Capsules - Licaps® capsules |
United Kingdom |
1915121 |
| Container |
Capsules - Licaps® capsules |
United States |
8377471 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Belgium |
2276445 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Canada |
2722271 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
China |
ZL200980117292.4A |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
France |
2276445 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Germany |
602009008078.4 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Italy |
2276445 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Japan |
5716212 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Korea - South |
1012359510000 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Mexico |
315642 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
Spain |
2276445 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
United Kingdom |
2276445 |
| Improved Capsule with Air-Vents |
Capsules - Licaps® capsules |
United States |
8715722 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
Belgium |
3025709 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
Canada |
2965425 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
France |
3025709 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
Germany |
3025709 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
Japan |
6706254 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
United Kingdom |
3025709 |
| Dosage Form Articles for External Mucosal Applications |
Capsules - Plantcaps® capsules |
United States |
10525011 |
| Hard Capsules |
Capsules - Plantcaps® capsules |
United States |
10130587 |
| Hard Capsules |
Capsules - Plantcaps® capsules |
United States |
10568839 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Belgium |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
France |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Germany |
602012011096.1 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Ireland |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Italy |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Japan |
5860480 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Netherlands |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Portugal |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
Spain |
2663294 |
| New Hard Capsules Comprising Pullulan |
Capsules - Plantcaps® capsules |
United Kingdom |
2663294 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
Belgium |
1539114 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
Canada |
2494045 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
France |
1539114 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
Germany |
60335991.4 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
Japan |
4652052 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
Spain |
1539114 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
United Kingdom |
1539114 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
United States |
7914820 |
| Film Coating For Tablets And Caplets |
Capsules - Press-Fit® Capsules |
United States |
8557294 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Belgium |
2083786 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Canada |
2667531 |
| Capsule Formation |
Capsules - Vcaps® capsules |
China |
ZL200780040046.4 |
| Capsule Formation |
Capsules - Vcaps® capsules |
France |
2083786 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Germany |
602007011963.4 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Italy |
2083786 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Japan |
5452227 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Korea - South |
1183713 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Mexico |
298202 |
| Capsule Formation |
Capsules - Vcaps® capsules |
Spain |
2083786 |
| Capsule Formation |
Capsules - Vcaps® capsules |
United Kingdom |
2083786 |
| Capsule Formation |
Capsules - Vcaps® capsules |
United States |
9138920 |
| Capsule Formation |
Capsules - Vcaps® capsules |
United States |
9211659 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Belgium |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Belgium |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
China |
ZL200780040028.6 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
France |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
France |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Germany |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Germany |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
India |
288423 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Italy |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Italy |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Japan |
5372761 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Korea - South |
1011702830000 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Mexico |
315891 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Netherlands |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Netherlands |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Spain |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Switzerland |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
United Kingdom |
2078042 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
United Kingdom |
3594248 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
United States |
10004692 |
| Hydroxypropyl Methyl Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
United States |
9655860 |
| Hydroxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Canada |
2667167 |
| Hyrdorxypropyl Methyll Cellulose Hard Capsules And Process Of Manufacture |
Capsules - Vcaps® capsules |
Indonesia |
IDP000039591 |
| Apparatus And Method For Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
United States |
7712634 |
| Apparatus And Method Of Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
United States |
7665633 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
France |
1765673 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
Germany |
602005010081.4 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
Italy |
1765673 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
Spain |
1765673 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
United Kingdom |
1765673 |
| Dispensing Small Quantities Of Particles |
Capsules - Xcelodose® System |
United States |
8074835 |
| Weighing Apparatus |
Capsules - Xcelodose® System |
France |
1792148 |
| Weighing Apparatus |
Capsules - Xcelodose® System |
Germany |
602005040670 |
| Weighing Apparatus |
Capsules - Xcelodose® System |
Japan |
5420684 |
| Weighing Apparatus |
Capsules - Xcelodose® System |
United Kingdom |
1792148 |
| Weighing Apparatus With Improved Cleaning Capabilities |
Capsules - Xcelodose® System |
United States |
7834279 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
China |
ZL201080056055.4 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Czech Republic |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
France |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Germany |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
India |
295113 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Italy |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Japan |
5911806 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Japan |
6239579 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Korea - South |
10-1761958 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Netherlands |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Spain |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Switzerland |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
Taiwan |
I469797 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
United Kingdom |
2509436 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
United States |
8470382 |
| Carnitine Granulate and Methods for its Production |
CARNIKING® L-carnitine |
United States |
9066868 |
| Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals |
CARNIKING® L-carnitine |
European Patent Office |
3154539 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
China |
ZL201080006619.3 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
Germany |
60 2010 004 833.0 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
Italy |
2393774 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
Japan |
5705745 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
Korea - South |
10-1699990 |
| Process for the Production of a Fatty Acid/Carnitine Derivative |
Carnitine Derivative Manufacturing Process |
United States |
8614343 |
| Method and Composition for Increasing Muscle Protein Synthesis and/or Functional Strength in Mammals |
Carnitine Formulation |
Brazil |
TBD |
| Method and Composition for Increasing Muscle Protein Synthesis and/or Functional Strength in Mammals |
Carnitine Formulation |
United States |
10888571 |
| A Process for the Enzymatic Production of Carnitine from ß-Lactones |
Carnitine Manufacturing |
Germany |
2737074 |
| A Process for the Enzymatic Production of Carnitine from ß-Lactones |
Carnitine Manufacturing |
Japan |
6169812 |
| A Process for the Enzymatic Production of Carnitine from ß-Lactones |
Carnitine Manufacturing |
Switzerland |
2737074 |
| A Process for the Enzymatic Production of Carnitine from ß-Lactones |
Carnitine Manufacturing |
United States |
9523106 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
China |
ZL201180019495.7 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Czech Republic |
2569275 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Germany |
2569275 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
India |
292185 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Italy |
2569275 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Japan |
6018046 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Korea - South |
10-1848763 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
Switzerland |
2569275 |
| A Process for the Hydrogenation of Ketoesters |
Carnitine Manufacturing |
United States |
8431741 |
| Methods for Decolorizing Compositions Comprising Betaines |
Carnitine Manufacturing |
United States |
9550726 |
| Methods for Decolorizing Compositions Comprising Be-taines |
Carnitine Manufacturing |
China |
ZL201380057952.0 |
| Methods for Decolorizing Compositions Comprising Be-taines |
Carnitine Manufacturing |
Germany |
2920143 |
| Methods for Decolorizing Compositions Comprising Be-taines |
Carnitine Manufacturing |
Italy |
502020000068287 |
| Methods for Decolorizing Compositions Comprising Be-taines |
Carnitine Manufacturing |
Japan |
6333275 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
China |
ZL200880117375.9 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
Germany |
60 2008 009 662.9 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
India |
271284 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
Italy |
2231587 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
Japan |
5155406 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
Korea - South |
1132589 |
| Process for the Preparation of Betaines |
Carnitine Manufacturing |
United States |
8168823 |
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
China |
ZL1280020003.0 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
Czech Republic |
2702032 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
Germany |
2702032 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
India |
308970 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
Italy |
2702032 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
Japan |
6012709 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
Switzerland |
2702032 |
|
| Process for the Production of 4-Chloroacetyl Chloride |
4-Chloroacetic Acid Esters |
Amides and Imides |
Carnitine Manufacturing |
United States |
9227905 |
|
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
China |
ZL201080006621.0 |
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
Germany |
2393578 |
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
Japan |
6242565 |
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
Korea - South |
10-1728562 |
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
Switzerland |
2393578 |
| Process for the Recovery of Betaines from Electrodialysis Waste Streams |
Carnitine Manufacturing |
United States |
9415346 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
China |
ZL201180042646.0 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Czech Republic |
2613778 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Germany |
2613778 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
India |
293603 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Italy |
2613778 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Japan |
5964831 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Korea - South |
10-1899015 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
Switzerland |
2613778 |
| Process for the Production of L-Carnitine Tartrate |
Carnitine Tartrate Manufacturing Process |
United States |
8779188 |
| Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals |
Carnitine Use |
Japan |
6982956 |
| Method for Decreasing Skeletal Muscle Damage and/or Oxidative Stress in Mammals |
Carnitine Use |
United States |
10016382 |
| Trimethylamine-N-Oxide Producing Agent for Treating Atheroma Formation |
Carnitine Use |
France |
3253381 |
| Trimethylamine-N-Oxide Producing Agent for Treating Atheroma Formation |
Carnitine Use |
Germany |
3253381 |
| Trimethylamine-N-Oxide Producing Agent for Treating Atheroma Formation |
Carnitine Use |
United Kingdom |
3253381 |
| Use of L-Carnitine |
Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function |
Carnitine Use |
France |
2694051 |
|
|
| Use of L-Carnitine |
Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function |
Carnitine Use |
Germany |
2694051 |
|
|
| Use of L-Carnitine |
Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function |
Carnitine Use |
Japan |
6608858 |
|
|
| Use of L-Carnitine |
Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function |
Carnitine Use |
United Kingdom |
2694051 |
|
|
| Use of L-Carnitine |
Salts and Derivatives Thereof for Reducing or Preventing Fatigue and Improving Cognitive Function |
Carnitine Use |
United States |
10130602 |
|
|
| Cell Culture System and Method |
Cell and Gene Therapies |
Korea - South |
10-2499475 |
| Cell Culture System and Method |
Cell and Gene Therapies |
United States |
11559811 |
| Scalable Process for Therapeutic Cell Concentration and Residual Clearance |
Cell and Gene Therapies |
United States |
10385307 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
France |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Germany |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Italy |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Netherlands |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Spain |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Sweden |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
Switzerland |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
United Kingdom |
2761024 |
| Molecular Targets and Methods for Formulation Screening and Preservative Efficacy Testing |
Cell and Gene Therapies - Bio Assays |
United States |
9512474 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Canada |
2924735 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
China |
ZL201480063730.4 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
France |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Germany |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Italy |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Japan |
6479775 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Netherlands |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Spain |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Sweden |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
Switzerland |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
United Kingdom |
3047020 |
| Methods for Nuclear Reprogramming of Cells |
Cell and Gene Therapies - iPSC |
United States |
10745668 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Australia |
2012255724 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Australia |
2016238891 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Canada |
2836578 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
France |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Germany |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Israel |
229462 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Italy |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Japan |
6140149 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Korea - South |
10-1970368 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Netherlands |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Spain |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Sweden |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Switzerland |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
United Kingdom |
2718424 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
United States |
9885019 |
| Passaging and Harvesting Formulation and Method for Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
United States |
10487312 |
| Passaging and Harvesting Formulation for Single-Cell Human Pluripotent Stem Cells |
Cell and Gene Therapies - iPSC |
Japan |
7092309 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Australia |
2017269371 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
China |
ZL201780032195.X |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
France |
3464571 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Germany |
3464571 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Israel |
262960 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Japan |
6908331 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Korea - South |
2450255 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
Switzerland |
3464571 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
United Kingdom |
3464571 |
| Methods for Isolating Adeno-Associated Virus Using a Polydiallyldialkylammonium Salt |
Cell and Gene Therapies - Viral Vector Manufacturing |
United States |
11427809 |
| Methods for Nuclear Reprogramming Using Synthetic Transcription Factors |
Cell and Gene Therapies - Viral Vector Manufacturing |
Israel |
255536 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
Australia |
2005247967 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
Canada |
2568438 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
France |
1756262 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
Germany |
1756262 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
Italy |
1756262 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
Switzerland |
1756262 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
United Kingdom |
1756262 |
| Advanced Tissue Engineering System |
Cocoon® Platform |
United States |
9499780 |
| Automated Cell Culture System |
Cocoon® Platform |
Canada |
2833001 |
| Automated Cell Culture System |
Cocoon® Platform |
United States |
9783768 |
| Automated System for Production of Tissue Engineered Products |
Cocoon® Platform |
United States |
8492140 |
| Automated System for Production of Tissue Engineered Products |
Cocoon® Platform |
United States |
9534195 |
| Automated Tissue Engineering System |
Cocoon® Platform |
United States |
10723986 |
| Cell Culture and Tissue Engineering Systems with Controlled Environmental Zones |
Cocoon® Platform |
United States |
11597905 |
| End-To-End Cell Therapy Automation |
Cocoon® Platform |
Korea - South |
10-2296580 |
| End-To-End Cell Therapy Automation |
Cocoon® Platform |
United States |
11447745 |
| End-To-End Cell Therapy Automation |
Cocoon® Platform |
United States |
11371018 |
| Polymeric Carriers and Methods |
Cocoon® Platform |
United States |
11560545 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
Canada |
2599823 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
France |
1730267 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
Germany |
1730267 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
Italy |
1730267 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
United Kingdom |
1730267 |
| Reverse-flow Perfusion of Three-Dimensional Scaffolds |
Cocoon® Platform |
United States |
8546142 |
| Support For Biologic Engineering Unit |
Cocoon® Platform |
China |
ZL202230469207.9 |
| Support For Biologic Engineering Unit |
Cocoon® Platform |
EUIPO |
009095987-0001 |
| Support For Biologic Engineering Unit |
Cocoon® Platform |
Singapore |
30202250206G |
| Support For Biologic Engineering Unit |
Cocoon® Platform |
United Kingdom |
6221024 |
| Device and Method for Improved Closure Integrity |
Container Testing |
China |
ZL201880059976.2 |
| Device and Method for Improved Closure Integrity |
Container Testing |
France |
3681571 |
| Device and Method for Improved Closure Integrity |
Container Testing |
Germany |
3681571 |
| Device and Method for Improved Closure Integrity |
Container Testing |
Hong Kong |
HK40025040 |
| Device and Method for Improved Closure Integrity |
Container Testing |
Japan |
7042901 |
| Device and Method for Improved Closure Integrity |
Container Testing |
Switzerland |
3681571 |
| Device and Method for Improved Closure Integrity |
Container Testing |
United Kingdom |
3681571 |
| Device and Method for Improved Closure Integrity Testing |
Container Testing |
United States |
10801913 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
China |
ZL201880059371.3 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
France |
3682219 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
Germany |
3682219 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
Hong Kong |
HK40025036 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
Japan |
6983310 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
Switzerland |
3682219 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
United Kingdom |
3682219 |
| Device and Method for Improved Container Closure Integrity Testing |
Container Testing |
United States |
10895514 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
France |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
Germany |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
Italy |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
Netherlands |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
Spain |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
Switzerland |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
United Kingdom |
3884252 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
United States |
11346742 |
| Device and Method for Leakage Testing of a Connection Between a Rubber Stopper and a Corresponding Drug Container |
Container Testing |
United States |
11499885 |
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
France |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
Germany |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
Italy |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
Netherlands |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
Spain |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
Switzerland |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
United Kingdom |
3911382 |
|
|
| Displacement Device |
Testing Device and Method for Leakage Testing of a Connection of a Tip Cap for a Syringe with the Syringe |
Container Testing |
United States |
11389599 |
|
|
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Canada |
2978080 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
France |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Germany |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Hong Kong |
HK 1248765 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
India |
385511 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Italy |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Japan |
6733872 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Spain |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Sweden |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
Switzerland |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
United Kingdom |
3262156 |
| Method for Pooling Hepatocytes |
DonorPlex® Pooled Donor Hepatocytes |
United States |
10159244 |
| Formulations To Achieve Rapid Dissolution Of Drug From Spray-Dried Dispersions In Capsules |
Dosage Form |
Japan |
6796083 |
| Immediate Release Dosage Forms Containing Solid Drug Dispersions |
Dosage Form |
United States |
9211261 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
China |
ZL201880006683.8 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
France |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
Germany |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
Italy |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
Netherlands |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
Sweden |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
Switzerland |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate |
Endotoxin Detection |
United Kingdom |
3552021 |
| Coagulogen-Free Clarified Limulus Amebocyte Lysate and Chromogenic Assay of Endotoxin |
Endotoxin Detection |
United States |
11352656 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
France |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Germany |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Italy |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Japan |
7044222 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Netherlands |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Sweden |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
Switzerland |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
United Kingdom |
3494226 |
| Method of Detecting an Endotoxin Using Limulus Amebocyte Lysate Substantially Free of Coagulogen |
Endotoxin Detection |
United States |
11156614 |
| Method for Preparation of 1 |
4-Sorbitan |
Excipients for Parenteral DP |
China |
ZL201980054956.0 |
|
|
| Method for Preparation of 1 |
4-Sorbitan |
Excipients for Parenteral DP |
Japan |
7148732 |
|
|
| Method for Preparation of 1 |
4-Sorbitan |
Excipients for Parenteral DP |
Korea - South |
10-2312129 |
|
|
| Method for Preparation of 1 |
4-Sorbitan |
Excipients for Parenteral DP |
United States |
11174236 |
|
|
| Continuous Reaction Micro-Reactor |
FlowPlate® Microreactor Technology |
China |
ZL201080017207.X |
| Continuous Reaction Micro-Reactor |
FlowPlate® Microreactor Technology |
Hong Kong |
HK1164779 |
| Continuous Reaction Micro-Reactor |
FlowPlate® Microreactor Technology |
Japan |
5774580 |
| Continuous Reaction Micro-Reactor |
FlowPlate® Microreactor Technology |
United States |
9302243 |
| Fluid Mixing Structure |
Continuous Reaction Unit |
Continuous Reaction Reactor And Method Of Using The Same |
FlowPlate® Microreactor Technology |
France |
3031518 |
|
| Fluid Mixing Structure |
Continuous Reaction Unit |
Continuous Reaction Reactor And Method Of Using The Same |
FlowPlate® Microreactor Technology |
Germany |
3031518 |
|
| Fluid Mixing Structure |
Continuous Reaction Unit |
Continuous Reaction Reactor And Method Of Using The Same |
FlowPlate® Microreactor Technology |
Japan |
6759208 |
|
| Fluid Mixing Structure |
Continuous Reaction Unit |
Continuous Reaction Reactor And Method Of Using The Same |
FlowPlate® Microreactor Technology |
United Kingdom |
3031518 |
|
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
China |
ZL200780027369 |
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
France |
2044087 |
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
Germany |
602007014375.6 |
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
Japan |
5512266 |
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
United Kingdom |
2044087 |
| Method For Grignard Type Reactions In Microreactors |
FlowPlate® Microreactor Technology |
United States |
7939698 |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
China |
ZL200880004269.X |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
France |
2109616 |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
Germany |
60 2008 002 321.4-08 |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
Japan |
5394258 |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
United Kingdom |
2109616 |
| Method For Lithium Exchange Reactions |
FlowPlate® Microreactor Technology |
United States |
8198487 |
| Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method |
FlowPlate® Microreactor Technology |
Japan |
5718335 |
| Method For Preventing Plugging Of A Continuous-Reaction Channel-System And Micro-Reactor For Carrying Out The Method |
FlowPlate® Microreactor Technology |
United States |
10058840 |
| Method Of Manufacturing A Reactor And Set Of Reactors |
FlowPlate® Microreactor Technology |
China |
ZL201080020562.2 |
| Method Of Manufacturing A Reactor And Set Of Reactors |
FlowPlate® Microreactor Technology |
Hong Kong |
1170447 |
| Method Of Manufacturing A Reactor And Set Of Reactors |
FlowPlate® Microreactor Technology |
Japan |
6062244 |
| Method Of Manufacturing A Reactor And Set Of Reactors |
FlowPlate® Microreactor Technology |
United States |
9023296 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
China |
ZL200780012236.5 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
France |
1839739 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
Germany |
1839739 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
Hong Kong |
1128007 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
Japan |
6234959 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United Kingdom |
1839739 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United States |
7919056 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United States |
8287824 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United States |
8512653 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United States |
9375698 |
| Micro-Reactor System Assembly |
FlowPlate® Microreactor Technology |
United States |
9962678 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
Belgium |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
France |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
Germany |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
Italy |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
Netherlands |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
Spain |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
United Kingdom |
3151815 |
| Stable Dosage Form Articles for Oral Administration |
Gelatin Capsule with Fill Formulation |
United States |
10016369 |
| Improved Collagen Dispersion and Method of Producing Same |
Granulated Carnitine and Manufacturing Process |
Korea - South |
10-1611374 |
| Improved Collagen Dispersion and Method of Producing Same |
Granulated Carnitine and Manufacturing Process |
Taiwan |
I510500 |
| Improved Collagen Dispersion and Method of Producing Same |
Granulated Carnitine and Manufacturing Process |
United States |
8748499 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
China |
ZL201080051331.8 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Czech Republic |
2501673 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Germany |
2501673 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
India |
308637 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Italy |
2501673 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Japan |
6234030 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Korea - South |
10-1823971 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
Switzerland |
2501673 |
| Methods for the Production of L-Carnitine |
Granulated Carnitine and Manufacturing Process |
United States |
8604237 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
China |
ZL201010262857.2 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
Czech Republic |
1901715 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
Germany |
60 2006 029 269.4 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
Italy |
1901715 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
Japan |
5149172 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
Korea - South |
1327700 |
| Spray-Drying Process for Producing a Dry Carnitine Powder or Granulate |
Granulated Carnitine and Manufacturing Process |
United States |
9084431 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Australia |
2006249087 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
China |
ZL200680017582.8 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
France |
1915394 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Germany |
1915394 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Hong Kong |
HK1120050 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
India |
263242 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Israel |
187100 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Italy |
1915394 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Japan |
4991705 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Korea - South |
1273829 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Spain |
1915394 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
Switzerland |
1915394 |
| High-Level Expression Of Recombinant Antibody In A Mammalian Host Cell |
GS GENE EXPRESSION SYSTEM® |
United Kingdom |
1915394 |
| Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene |
GS GENE EXPRESSION SYSTEM® |
Australia |
2006237193 |
| Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene |
GS GENE EXPRESSION SYSTEM® |
Hong Kong |
1119737 |
| Mammalian Expression Vector Comprising The mCMV Promoter And First Intron Of hCMV Major Immediate Early Gene |
GS GENE EXPRESSION SYSTEM® |
India |
257246 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
China |
ZL200880018842.2 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
France |
2152728 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
Germany |
60 2008 022 892.4 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
Japan |
5301534 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
Singapore |
182147 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
Spain |
2152728 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
United Kingdom |
2152728 |
| Mammalian Expression Vector With A Highly Efficient Secretory Signal Sequence |
GS GENE EXPRESSION SYSTEM® |
United States |
8241870 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Australia |
2003251434 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Australia |
2009200665 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Austria |
E412761 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Belgium |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Bulgaria |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Canada |
2489016 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Canada |
2672809 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
China |
ZL03816914.2 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Czech Republic |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Denmark |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Estonia |
E002975 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Finland |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
France |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Germany |
603 24 430.0-08 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Greece |
20090400053 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Hong Kong |
1081595 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Hungary |
E004531 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
India |
229233 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Ireland |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Italy |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Japan |
4430535 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Japan |
5502406 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Japan |
5209693 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Korea - South |
976098 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Luxembourg |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Netherlands |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Portugal |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Romania |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Singapore |
109715 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Slovakia |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Slovenia |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Spain |
2314248 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Sweden |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Switzerland |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
Türkiye |
2009 00640 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
United Kingdom |
1525320 |
| Method Of Expressing Recombinant Protein In CHO Cells |
GS GENE EXPRESSION SYSTEM® |
United States |
7932087 |
| Buffer Solutions |
Ibex® Solutions |
Japan |
7075927 |
| Customizable Facility |
Ibex® Solutions |
Israel |
261709 |
| Customizable Facility |
Ibex® Solutions |
Japan |
7009378 |
| Customizable Facility |
Ibex® Solutions |
Japan |
3239085 |
| Customizable Facility |
Ibex® Solutions |
Korea - South |
10-2423233 |
| Customizable Facility |
Ibex® Solutions |
Korea - South |
10-2480770 |
| Customizable Facility |
Ibex® Solutions |
Singapore |
11201900528P |
| Customizable Facility |
Ibex® Solutions |
United States |
11236520 |
| Customizable Facility |
Ibex® Solutions |
United States |
10689873 |
| Customizable Facility |
Ibex® Solutions |
United States |
11377865 |
| Customizable Facility |
Ibex® Solutions |
United States |
11613900 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
China |
ZL201280010479.6 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
China |
ZL201510163661.0 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
France |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Germany |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Hong Kong |
1186668 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Hong Kong |
1213773 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Italy |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Japan |
5559439 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Japan |
6169520 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Netherlands |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Spain |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
Switzerland |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
United Kingdom |
2678037 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
United States |
10294270 |
| Branched Linkers For Protein Drug Conjugates |
Linkers for ADCs |
United States |
10214560 |
| A Method For The Reduction Of Viral Titer In Pharmaceuticals |
Mammalian Biopharmaceutical Services |
United States |
11034721 |
| A Process For Creating Reference Data For Predicting Concentrations Of Quality Attributes |
Mammalian Biopharmaceutical Services |
United States |
11568955 |
| Antibody Purification By Protein A And Ion Exchange Chromatography |
Mammalian Biopharmaceutical Services |
China |
ZL200480009347.7 |
| Antibody Purification By Protein A And Ion Exchange Chromatography |
Mammalian Biopharmaceutical Services |
Japan |
5752558 |
| Antibody Purification By Protein A And Ion Exchange Chromatography |
Mammalian Biopharmaceutical Services |
Singapore |
114308 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Belgium |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
France |
2393912 |
| Bioreactor For The Cultivation of Mammalian Cells |
Mammalian Biopharmaceutical Services |
France |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Germany |
602010064092.2. |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Germany |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Italy |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Japan |
6121374 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Spain |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Switzerland |
2393912 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
Switzerland |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United Kingdom |
2393912 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United Kingdom |
3540040 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United States |
9783771 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United States |
10883076 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United States |
9670446 |
| Bioreactor For The Cultivation Of Mammalian Cells |
Mammalian Biopharmaceutical Services |
United States |
10179898 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
France |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Germany |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Israel |
284460 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Italy |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Netherlands |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Spain |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Sweden |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
Switzerland |
3752592 |
| Buffer Formulation Method And System |
Mammalian Biopharmaceutical Services |
United Kingdom |
3752592 |
| CL And/Or CH1 Mutated Antibodies For Drug Conjugation |
Mammalian Biopharmaceutical Services |
Japan |
6932649 |
| CL And/Or CH1 Mutated Antibodies For Drug Conjugation |
Mammalian Biopharmaceutical Services |
United States |
10953106 |
| Compositions And Methods For The Detection Of Host Cell Proteins |
Mammalian Biopharmaceutical Services |
Korea - South |
10-2408260 |
| Compositions And Methods For The Detection Of Host Cell Proteins |
Mammalian Biopharmaceutical Services |
United States |
11353468 |
| Continuous Blade Impeller |
Mammalian Biopharmaceutical Services |
Israel |
287170 |
| Crispr-Associated (Cas) Proteins with Reduced Immunogenicity |
Mammalian Biopharmaceutical Services |
United States |
11566052 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
France |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
Germany |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
Ireland |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
Spain |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
Switzerland |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
United Kingdom |
2800966 |
| Dielectric Spectroscopy Methods and Apparatus |
Mammalian Biopharmaceutical Services |
United States |
9568449 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Australia |
2013320157 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Austria |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Austria |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Belgium |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Belgium |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Brazil |
1120150056040 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Canada |
2880750 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
China |
ZL201380049575.6 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Czech Republic |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Czech Republic |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Denmark |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Denmark |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Finland |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Finland |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
France |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
France |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Germany |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Germany |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Hong Kong |
HK1206061 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Hungary |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Hungary |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
India |
333092 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Ireland |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Ireland |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Israel |
237171 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Italy |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Italy |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Japan |
6162246 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Korea - South |
10-1757083 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Mexico |
371007 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Netherlands |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Netherlands |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Norway |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Norway |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Poland |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Poland |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Singapore |
11201502243Y |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Spain |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Spain |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Sweden |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Sweden |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Switzerland |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Switzerland |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
Taiwan |
I507526 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
United Kingdom |
2711426 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
United Kingdom |
2898077 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
United States |
9777290 |
| Expression Vectors Comprising Chimeric Cytomegalovirus Promoter And Enhancer Sequences |
Mammalian Biopharmaceutical Services |
United States |
10294491 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
EUIPO |
001238208 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
EUIPO |
001268353 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
Japan |
1431555 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
United Kingdom |
90012683530001 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
United Kingdom |
90012683530002 |
| Impeller Arrangement for Fermenter |
Mammalian Biopharmaceutical Services |
United States |
D664262 |
| Inhibition Of Protein Degradation For Improved Production |
Mammalian Biopharmaceutical Services |
Japan |
7049253 |
| Inhibition Of Protein Degradation For Improved Production |
Mammalian Biopharmaceutical Services |
United States |
11320422 |
| Mammalian Expression System |
Mammalian Biopharmaceutical Services |
France |
3341484 |
| Mammalian Expression System |
Mammalian Biopharmaceutical Services |
Germany |
3341484 |
| Mammalian Expression System |
Mammalian Biopharmaceutical Services |
Switzerland |
3341484 |
| Mammalian Expression System |
Mammalian Biopharmaceutical Services |
United Kingdom |
3341484 |
| Measuring |
Monitoring And Control Of Bioprocesses Using Spectroscopy Technologies And Multivariate Data Analysis |
Mammalian Biopharmaceutical Services |
United States |
11609120 |
|
|
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Austria |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Belgium |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Canada |
2589823 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
China |
ZL200580041600.1 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Denmark |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
France |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Germany |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Hong Kong |
1115155 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Ireland |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Israel |
183609 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Italy |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Japan |
5080269 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Netherlands |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Singapore |
132972 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Spain |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
Switzerland |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
United Kingdom |
1824961 |
| Melibiose Operon Expression System |
Mammalian Biopharmaceutical Services |
United States |
8735099 |
| Method And System For Providing Buffer Solutions |
Mammalian Biopharmaceutical Services |
United States |
10669518 |
| Method For Stabilizing Proteins |
Mammalian Biopharmaceutical Services |
Australia |
2017277761 |
| Method For Stabilizing Proteins |
Mammalian Biopharmaceutical Services |
Korea - South |
10-2451374 |
| Method For Stabilizing Proteins |
Mammalian Biopharmaceutical Services |
Korea - South |
10-2499718 |
| Method For Stabilizing Proteins |
Mammalian Biopharmaceutical Services |
United States |
10975409 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
Belgium |
1516275 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
France |
1516275 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
Germany |
1516275 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
Switzerland |
1516275 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
United Kingdom |
1516275 |
| Method |
Computing Routine |
Device For Predicting Properties Of Mhc/Peptide Complexes |
And Data And Peptides Produced Therefrom |
Mammalian Biopharmaceutical Services |
United States |
7702465 |
| Methods And Compositions For Producing Therapeutic Product Variants |
Mammalian Biopharmaceutical Services |
Japan |
7252896 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
China |
ZL201980011543.4 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
France |
3645720 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
Germany |
3645720 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
Italy |
3645720 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
Japan |
7108036 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
Spain |
3645720 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
Switzerland |
3645720 |
| Methods Of Cell Selection And Modifying Cell Metabolism |
Mammalian Biopharmaceutical Services |
United Kingdom |
3645720 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Australia |
2017259010 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Canada |
3023038 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
France |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Germany |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Israel |
262646 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Italy |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Japan |
6959942 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Spain |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
Switzerland |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
United Kingdom |
3452608 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
United States |
10655111 |
| Modulation Of Lipid Metabolism For Protein Production |
Mammalian Biopharmaceutical Services |
United States |
11434474 |
| Process And System For Propagating Cell Cultures While Preventing Lactate Accumulation |
Mammalian Biopharmaceutical Services |
United States |
11634680 |
| Protein A Chromatography |
Mammalian Biopharmaceutical Services |
United States |
7847071 |
| Reactor Surface Finish Effect On Cleanability |
Mammalian Biopharmaceutical Services |
United States |
10808216 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Austria |
E466090 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Belgium |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Canada |
2589937 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
China |
ZL200580041794.5 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Denmark |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
France |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Germany |
60 2005 020 972.7 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Hong Kong |
1115156 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Israel |
183608 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Italy |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Japan |
5069124 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Netherlands |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Singapore |
132976 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Singapore |
149071 |
| Rhamnose promoter expression system |
Mammalian Biopharmaceutical Services |
Spain |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Sweden |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
Switzerland |
1824980 |
| Rhamnose promoter expression system |
Mammalian Biopharmaceutical Services |
United Kingdom |
1824980 |
| Rhamnose Promoter Expression System |
Mammalian Biopharmaceutical Services |
United States |
9279128 |
| Rupture Disks For Bioreactors And Methods Of Using Same |
Mammalian Biopharmaceutical Services |
China |
ZL201780083077.1 |
| Rupture Disks For Bioreactors And Methods Of Using Same |
Mammalian Biopharmaceutical Services |
United States |
10436338 |
| Single Use Bioreactor |
Mammalian Biopharmaceutical Services |
Japan |
6942736 |
| Single Use Bioreactor |
Mammalian Biopharmaceutical Services |
Korea - South |
10-2398310 |
| Single Use Bioreactor |
Mammalian Biopharmaceutical Services |
United States |
10801003 |
| Single Use Bioreactor |
Mammalian Biopharmaceutical Services |
United States |
11371002 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
China |
ZL201380032837.8 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
France |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Germany |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Hong Kong |
1202580 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Ireland |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Italy |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Japan |
6053923 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Korea - South |
10-1761709 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
Spain |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
United Kingdom |
2864489 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
United States |
10280436 |
| Site-Specific Integration |
Mammalian Biopharmaceutical Services |
United States |
11326185 |
| System And Method For Regulating Cell Culture Based Production Of Biologics |
Mammalian Biopharmaceutical Services |
Australia |
2016338676 |
| System And Method For Regulating Cell Culture Based Production Of Biologics |
Mammalian Biopharmaceutical Services |
Israel |
258633 |
| System And Method For Regulating Cell Culture Based Production Of Biologics |
Mammalian Biopharmaceutical Services |
Japan |
7097298 |
| System And Method For Regulating Cell Culture Based Production Of Biologics |
Mammalian Biopharmaceutical Services |
Singapore |
11201803017Q |
| System And Method For Regulating Cell Culture Based Production Of Biologics |
Mammalian Biopharmaceutical Services |
United States |
10570363 |
| Variable Diameter Bioreactors |
Mammalian Biopharmaceutical Services |
United States |
10370629 |
| Wireless Sensor Information Monitoring |
Mammalian Biopharmaceutical Services |
United States |
10244406 |
| Wireless Sensor Information Monitoring |
Mammalian Biopharmaceutical Services |
United States |
11006260 |
| Gelling Multiparticulates |
Multiparticulate Composition |
United States |
11510877 |
| Lipid Multiparticulate Formulations |
Multiparticulate Composition |
United States |
11324699 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
Belgium |
2949309 |
| Apparatus and Process for Filling Particular Materials |
Multiparticulates |
France |
2949309 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
Germany |
602014004180.9 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
Italy |
2949309 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
Spain |
2949309 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
United Kingdom |
2949309 |
| Apparatus And Process For Filling Particular Materials |
Multiparticulates |
United States |
10835451 |
| Extrusion Process For Forming Chemically Stable Drug Multiparticulates |
Multiparticulates |
United States |
7625507 |
| Method For Making Pharmaceutical Multiparticulates |
Multiparticulates |
France |
1691787 |
| Method For Making Pharmaceutical Multiparticulates |
Multiparticulates |
Germany |
602004014805.9 |
| Method For Making Pharmaceutical Multiparticulates |
Multiparticulates |
United Kingdom |
1691787 |
| Multiparticulate Compositions With Improved Stability |
Multiparticulates |
United States |
7736672 |
| Multiparticulate Crystalline Drug Compositions Having Controlled Release Profiles |
Multiparticulates |
United States |
7887844 |
| Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core |
Multiparticulates |
France |
2091519 |
| Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core |
Multiparticulates |
Germany |
602007041896.8 |
| Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core |
Multiparticulates |
United Kingdom |
2091519 |
| Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core |
Multiparticulates |
United States |
10357462 |
| Multiparticulates Of Spray-Coated Drug And Polymer On A Meltable Core |
Multiparticulates |
United States |
11116728 |
| Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use |
Multiparticulates |
Belgium |
3154529 |
| Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use |
Multiparticulates |
France |
3154529 |
| Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use |
Multiparticulates |
Germany |
3154529 |
| Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use |
Multiparticulates |
Switzerland |
3154529 |
| Orally Disintegrating Tablet Containing Solid Lipid Particles And Methods For Their Preparation And Use |
Multiparticulates |
United Kingdom |
3154529 |
| Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride |
Multiparticulates |
Belgium |
1689368 |
| Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride |
Multiparticulates |
France |
1689368 |
| Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride |
Multiparticulates |
Germany |
602004050023.2 |
| Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride |
Multiparticulates |
Italy |
1689368 |
| Spray-Congeal Process Using An Extruder For Preparing Multiparticulate Crystalline Drug Compositions Containing Preferably A Poloxamer And A Glyceride |
Multiparticulates |
United Kingdom |
1689368 |
| Taste-Masked Drugs In Rupturing Multiparticulates |
Multiparticulates |
France |
1737433 |
| Taste-Masked Drugs In Rupturing Multiparticulates |
Multiparticulates |
Germany |
602005003343.2 |
| Taste-Masked Drugs In Rupturing Multiparticulates |
Multiparticulates |
United Kingdom |
1737433 |
| Taste-Masked Drugs In Rupturing Multiparticulates |
Multiparticulates |
United States |
8236349 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Australia |
2004233290 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbama Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Singapore |
114840 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbamate Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
China |
ZL200480005692.3 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbamate Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Hong Kong |
1148790 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbamate Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Japan |
4987469 |
| Assay for Detecting Mycoplasma by Measuring Acetate Kinase or Carbamate Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Korea - South |
1162738 |
| Assay Methods and Materials |
MYCOALERT® Mycoplasma Detection Kit |
Canada |
2512636 |
| Method for Detecting Mycoplasma by Determining Acetate Kinase or Carbamate Kinase Activity |
MYCOALERT® Mycoplasma Detection Kit |
Germany |
2264181 |
| Method to Detect the Presence of Mycoplasm in a Test Sample |
Use of Acetyl Phosphate or a Precursor Thereof and/or Carbamoyl Phosphate or a Precursor Thereof |
and Kit for Use in the Detection of Mycoplasm Contamination |
MYCOALERT® Mycoplasma Detection Kit |
Brazil |
PI0407750-4 |
|
| Methods and Aids for the Detection of Mycoplasma |
MYCOALERT® Mycoplasma Detection Kit |
Norway |
333474 |
| Mycopolasma Detecting Methods and Materials |
MYCOALERT® Mycoplasma Detection Kit |
United States |
7585644 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Austria |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Belgium |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Denmark |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Finland |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
France |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Germany |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Ireland |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Italy |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Japan |
6013419 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Korea - South |
1686260 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Netherlands |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Norway |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Spain |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Sweden |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
Switzerland |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
United Kingdom |
2208780 |
| A Method and Device for the Electrial Treatment of a Plurality of Containers |
Nucleofector® System |
United States |
9284525 |
| Buffer Solution for Electroporation and a Method Comprising the Use of the Same
Nucleofector Device |
Nucleofector® System |
United States |
7332332 |
| Buffer Solution for Electroporation and a Method Comprising the Use of the Same
Nucleofector Device |
Nucleofector® System |
United States |
8039259 |
| Buffer Solution for Electroporation and a Method Comprising the Use of the Same
Nucleofector Device |
Nucleofector® System |
United States |
8003389 |
| Circuit Arrangement for Injecting Nucleic Acids and Other Biologically Active Molecules into the Nucleus of Higher Eucaryotic Cells Using Electrical Current |
Nucleofector® System |
United States |
8173416 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Australia |
2005224452 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Australia |
2011200804 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Australia |
2011244905 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Austria |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Austria |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Belgium |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Belgium |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Canada |
2559580 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
China |
ZL200580007908.4 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
China |
ZL201210074701.0 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Czech Republic |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Denmark |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
France |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
France |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Germany |
502004009820.7 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Germany |
502004005342.4 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Italy |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Italy |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Japan |
4680254 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Korea - South |
1077008 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Netherlands |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Netherlands |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Poland |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Spain |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Spain |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Sweden |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Sweden |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Switzerland |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
Switzerland |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
United Kingdom |
1577378 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
United Kingdom |
1702677 |
| Container and Device for Generating Electric Fields in Different Chambers |
Nucleofector® System |
United States |
8101401 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Austria |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Belgium |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
France |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Germany |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Italy |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Japan |
5560288 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Korea - South |
1686258 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Netherlands |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Spain |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Sweden |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
Switzerland |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
United Kingdom |
2208779 |
| Container with a Plurality of Reaction Spaces and Electrodes |
Nucleofector® System |
United States |
9080139 |
| Container with at Least One Electrodenucleofector Solutions |
Nucleofector® System |
United States |
7678564 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Australia |
2015254739 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Australia |
2015254741 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Australia |
2018205130 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Austria |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Austria |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Belgium |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Belgium |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Canada |
2946472 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Canada |
2946666 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
China |
ZL201580022290.2 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
China |
ZL201580022367.6 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Denmark |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Denmark |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Denmark |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Finland |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Finland |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
France |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
France |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
France |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Germany |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Germany |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Germany |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
India |
364412 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
India |
359428 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Ireland |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Ireland |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Italy |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Italy |
502019000085478 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Italy |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Japan |
6642875 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Japan |
6750810 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Korea - South |
10-2412820 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Korea - South |
10-2407937 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Netherlands |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Netherlands |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Netherlands |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Norway |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Norway |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Spain |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Spain |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Spain |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Sweden |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Sweden |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Sweden |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Switzerland |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Switzerland |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
Switzerland |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United Kingdom |
2940120 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United Kingdom |
3260163 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United Kingdom |
2940121 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United States |
10336996 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United States |
10633646 |
| Device and Method for Large Volume Transfection |
Nucleofector® System |
United States |
11352615 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
China |
ZL03824843.3 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
Denmark |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
Finland |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
France |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
Germany |
50312452.4 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
Sweden |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
Switzerland |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
United Kingdom |
1543102 |
| Device and Method for Processing Biological Material |
Nucleofector® System |
United States |
7704727 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
France |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Germany |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Italy |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Netherlands |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Spain |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Sweden |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
Switzerland |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
United Kingdom |
1961807 |
| Device and Method for Stabilising the Flow Through a Chamber |
Nucleofector® System |
United States |
8450102 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Austria |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
France |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Germany |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Italy |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Netherlands |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Spain |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Sweden |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
Switzerland |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
United Kingdom |
1607484 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
United States |
7732175 |
| Method and Circuit Arrangement for Treating Biomaterial |
Nucleofector® System |
United States |
8058042 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Austria |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Belgium |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Denmark |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Finland |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
France |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Germany |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Ireland |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Italy |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Netherlands |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Norway |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Spain |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Sweden |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
Switzerland |
3750983 |
| Method and Device for Controlling the Filling Level in a Chamber |
Nucleofector® System |
United Kingdom |
3750983 |
| Method and Device for the Electrical Treatment of Reaction Spaces |
Nucleofector® System |
Japan |
5926560 |
| Method and Device for the Electrical Treatment of Reaction Spaces |
Nucleofector® System |
United States |
9249384 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
China |
ZL201180030236.4 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
China |
ZL201180030237.9 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
France |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
France |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Germany |
502010016602.5 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Germany |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Ireland |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Ireland |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Japan |
5840204 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Japan |
5885144 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Korea - South |
10-1853514 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Korea - South |
10-1853515 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Netherlands |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Netherlands |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Spain |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Spain |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Sweden |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Sweden |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Switzerland |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
Switzerland |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
United Kingdom |
2399984 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
United Kingdom |
2399985 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
United States |
9701954 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
United States |
9624486 |
| Method and Electrode Assembly for Treating Adherent Cells |
Nucleofector® System |
United States |
11021698 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produced by this Method |
Nucleofector® System |
United States |
8895152 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Australia |
2004283543 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Canada |
2542902 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
France |
1525900 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
France |
1698372 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Germany |
50303219.0 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Germany |
50312163.0 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Japan |
5032847 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Japan |
5124661 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Korea - South |
1130878 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Switzerland |
1525900 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
Switzerland |
1698372 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
United Kingdom |
1525900 |
| Method for Generating an Electrically Contactable Area on a Doped Polymer and Formed Body Produces by This Method |
Nucleofector® System |
United Kingdom |
1698372 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Australia |
2006268953 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Canada |
2613984 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
China |
ZL200680024248.5 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
France |
1741778 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Germany |
502005002350.1 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Hong Kong |
1122840 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Japan |
4982489 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
Switzerland |
1741778 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
United Kingdom |
1741778 |
| Method for Treating Small Volumes with Electrical Current |
Nucleofector® System |
United States |
7700357 |
| Methods And Compositions For Maintaining Active Agents In Intra-Articular Spaces |
Other Solubilization |
United States |
9084727 |
| Nanoparticles Comprising Drug |
A Non-Ionizable Cellulosic Polymer And Tocopheryl Polyethylene Glocol Succinate |
Other Solubilization |
United States |
9545384 |
|
|
| Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material |
Other Solubilization |
France |
2231169 |
| Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material |
Other Solubilization |
Germany |
602008044103.2 |
| Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material |
Other Solubilization |
United Kingdom |
2231169 |
| Pharmaceutical Compositions Comprising Nanoparticles And A Resuspending Material |
Other Solubilization |
United States |
9724362 |
| Pharmaceutical Compositions Containing A Solid Dispersion Of A Poorly-Soluble Drug And A Solubility-Enhancing Polymers |
Other Solubilization |
United States |
8236328 |
| Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials |
Other Solubilization |
France |
1653927 |
| Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials |
Other Solubilization |
Germany |
602004036099.6 |
| Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials |
Other Solubilization |
Ireland |
1653927 |
| Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials |
Other Solubilization |
United Kingdom |
1653927 |
| Pharmaceutical Compositions Of Semi-Ordered Drugs And Polymers |
Other Solubilization |
United States |
8257739 |
| Pharmaceutical Dosage Forms Comprising A Low-Solubility Drug And A Polymer |
Other Solubilization |
United States |
9445998 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Belgium |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
France |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Germany |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Ireland |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Japan |
6650933 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Portugal |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
Switzerland |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
United Kingdom |
3212169 |
| Process For Forming Active Domains Dispersed In A Matrix |
Other Solubilization |
United States |
11364203 |
| REISSUE-Pharmaceutical Compositions Of Adsorbates Of Amorphous Drugs And Lipophilic Microphase-Forming Materials |
Other Solubilization |
United States |
RE47033 |
| Single-Use Spray Drying Components And Methods Of Using The Same |
Particle Engineering - Alt Spray Dryers |
European Patent Office |
3676548 |
| Single-Use Spray Drying Components And Methods Of Using The Same |
Particle Engineering - Alt Spray Dryers |
Japan |
7184877 |
| Single-Use Spray Drying Components And Methods Of Using The Same |
Particle Engineering - Alt Spray Dryers |
United States |
11619445 |
| Dynamically Controlling an Automated System |
PyroTec® Pro System |
Japan |
7227911 |
| Dynamically Controlling an Automated System |
PyroTec® Pro System |
Korea - South |
10-2507099 |
| Dynamically Controlling an Automated System |
PyroTec® Pro System |
Mexico |
387422 |
| Dynamically Controlling an Automated System |
PyroTec® Pro System |
United States |
10768190 |
| Dynamically Controlling an Automated System |
PyroTec® Pro System |
United States |
10928407 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
China |
ZL201780060547.2 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
France |
3519100 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
Germany |
3519100 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
Hong Kong |
HK40008244 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
Japan |
7068319 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
United Kingdom |
3519100 |
| Apparatus For The Micronization Of Powdered Material With The Capacity To Prevent Incrustations |
Small Molecules - Micronization |
United States |
11260396 |
| Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills |
Small Molecules - Micronization |
Canada |
2862553 |
| Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills |
Small Molecules - Micronization |
Germany |
2806856 |
| Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills |
Small Molecules - Micronization |
Italy |
1409966 |
| Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills |
Small Molecules - Micronization |
Japan |
6158225 |
| Drug/Carrier Inclusion Composites Prepared By A Mechano-Chemical Activation Process Using High-Energy Fluid Jet Mills |
Small Molecules - Micronization |
Switzerland |
2806856 |
| Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General |
With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised |
And Corresponding Process For Micronisation Of A Powde |
Small Molecules - Micronization |
Germany |
2838661 |
|
| Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General |
With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised |
And Corresponding Process For Micronisation Of A Powde |
Small Molecules - Micronization |
Italy |
1411465 |
|
| Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General |
With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised |
And Corresponding Process For Micronisation Of A Powde |
Small Molecules - Micronization |
Switzerland |
2838661 |
|
| Spiral Jet Mill Apparatus For Micronisation Of A Powdered Material Or A Material Containing Particles In General |
With A Novel System For Feeding And Dispensing The Powdered Material To Be Micronised |
And Corresponding Process For Micronisation Of A Powde |
Small Molecules - Micronization |
United States |
9427743 |
|
| Drying Of Drug-Containing Particles |
Spray Drying |
Belgium |
1855652 |
| Drying Of Drug-Containing Particles |
Spray Drying |
France |
1855652 |
| Drying Of Drug-Containing Particles |
Spray Drying |
France |
2043610 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Germany |
602006047398.2 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Germany |
602007041938.7 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Ireland |
1855652 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Ireland |
2043610 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Portugal |
1855652 |
| Drying Of Drug-Containing Particles |
Spray Drying |
Portugal |
2043610 |
| Drying Of Drug-Containing Particles |
Spray Drying |
United Kingdom |
1855652 |
| Drying Of Drug-Containing Particles |
Spray Drying |
United Kingdom |
2043610 |
| Drying Of Drug-Containing Particles |
Spray Drying |
United States |
9265731 |
| Drying Of Drug-Containing Particles |
Spray Drying |
United States |
8834929 |
| High-Temperature Spray Drying Process And Apparatus |
Spray Drying |
United States |
9248584 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
France |
1653928 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
Germany |
602004036819.9 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
Ireland |
1653928 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
Portugal |
1653928 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
Taiwan |
I290852 |
| Spray Drying Processes For Forming Solid Amorphous Dispersions Of Drugs And Polymers |
Spray Drying |
United Kingdom |
1653928 |
| Spray-Drying Process |
Spray Drying |
Belgium |
3130396 |
| Spray-Drying Process |
Spray Drying |
France |
2411137 |
| Spray-Drying Process |
Spray Drying |
France |
3130396 |
| Spray-Drying Process |
Spray Drying |
Germany |
602010036172.1 |
| Spray-Drying Process |
Spray Drying |
Germany |
3130396 |
| Spray-Drying Process |
Spray Drying |
Ireland |
3130396 |
| Spray-Drying Process |
Spray Drying |
Italy |
3130396 |
| Spray-Drying Process |
Spray Drying |
Portugal |
3130396 |
| Spray-Drying Process |
Spray Drying |
Spain |
3130396 |
| Spray-Drying Process |
Spray Drying |
Switzerland |
3130396 |
| Spray-Drying Process |
Spray Drying |
United Kingdom |
2411137 |
| Spray-Drying Process |
Spray Drying |
United Kingdom |
3130396 |
| Spray-Drying Process |
Spray Drying |
United States |
9724664 |
| Spray-Drying Process |
Spray Drying |
United States |
10300443 |
| Spray-Drying Process |
Spray Drying |
United States |
10675602 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Belgium |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
China |
ZL201980032910.9 |
| Capsules With Opacifier |
TiO2 Free Capsules |
France |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Germany |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Italy |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Netherlands |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Spain |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
Switzerland |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
United Kingdom |
3758685 |
| Capsules With Opacifier |
TiO2 Free Capsules |
United States |
11517535 |
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Belgium |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
France |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Germany |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Italy |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Netherlands |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Spain |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
Switzerland |
3983477 |
|
|
| Film |
Capsule And Film-Forming Composition Comprising Water-Soluble Salt As Opacifying Agent |
TiO2 Free Capsules |
United Kingdom |
3983477 |
|
|
| Film-Forming Composition Comprising Surfactant Or Surfactant And Salt As An Opacifying Agent |
TiO2 Free Capsules |
Japan |
6887456 |
| Pullulan Capsules |
TiO2 Free Capsules |
United States |
11576870 |
| Method for Producing Biologically Active Products |
Undenatured Collagen Composition and Manufacturing Process |
United States |
7083820 |
| Method for Producing Biologically Active Products |
Undenatured Collagen Composition and Manufacturing Process |
United States |
7846487 |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Australia |
2014202041 |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Canada |
2846644 |
| Method of Reducing Exercise-Induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Chile |
61835 |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Korea - South |
10-1664290 |
| Method of Reducing Exercise-Induced Joint Pain in Non-Arthritic Mammals |
Undenatured Collagen Use |
Malaysia |
MY-180106-A |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Mexico |
347669 |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Philippines |
2014/50143 |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
Singapore |
11201403524R |
| Method of Reducing Exercise-induced Joint Pain in Non-arthritic Mammals |
Undenatured Collagen Use |
United States |
9066926 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
3125217 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
7061234 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2495283 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3874047 |
| Carbon-Source Regulated Protein Production in a Recombinant Host Cell |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3874047 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
ATE1155873 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2903568 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
241340 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6698352 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2128959 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Singapore |
11201507557U |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2970994 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
9150870 |
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10 |
428 |
123 |
|
| Constitutive Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
11168117 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
843821 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
1231985 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201380056279.9 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Hong Kong |
HK1208037 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
238420 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
266700 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6556625 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
102079293 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Singapore |
11201502745X |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2912053 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3130598 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10160988 |
| Expression Sequences |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
11359223 |
| Improved Fermentation Process |
XS Technologies® - Microbial Biopharmaceutical Services |
India |
385062 |
| Improved Fermentation Process |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6974341 |
| Improved Fermentation Process |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
11377677 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
965820 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2803719 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201180042739.3 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
5997140 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Poland |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2591121 |
| Production Cell Line |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
8962277 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2016303026 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2992170 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL2016800583888 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Hong Kong |
HK1251256 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
25700 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6833812 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2253479 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3332005 |
| Promoter Variants |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10752907 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Lithuania |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Poland |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3663401 |
| Purification Process for Biological Molecules such as Plasmid DNA using Anionic
Exchange Chromatography |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3663401 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2015248815 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201580032989.7 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
248376 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
7062633 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2373954 |
| Recombinant Host Cell Engineered to Overexpress Helper Proteins |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10865416 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2015248807 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201580032885.6 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
602015034267.4 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
India |
400397 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
248361 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6982607 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2291978 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3132039 |
| Recombinant Host Cell for Expressing Proteins of Interest |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10590427 |
| Recombinant Host Cell with Altered Membrane Lipid Composition |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2018241920 |
| Recombinant Host Cell with Altered Membrane Lipid Composition |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
7189145 |
| Recombinant Host Cell with Altered Membrane Lipid Composition |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
11479798 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
ATE1107543 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2849856 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
India |
414860 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
231859 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6113736 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-1954389 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2128957 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Singapore |
10201602673P |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2764016 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
3508494 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
9512432 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
10301634 |
| Regulatable Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
11401523 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2011284844 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2803654 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201180036765.5 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Czech Republic |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Eurasian Patent Office |
034074 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Finland |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Hong Kong |
1184496 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
India |
344138 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Israel |
223864 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
6071878 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-1904140 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-2022884 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Mexico |
352068 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Norway |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Poland |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Russia |
034074 |
| Regulation of inducible promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Singapore |
187024 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
South Africa |
2012/09268 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Taiwan |
I515295 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
Türkiye |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2722390 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
9464294 |
| Regulation of Inducible Promoters |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
9970017 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Australia |
2010283807 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Austria |
578997 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Belgium |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Brazil |
112012002973-8 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Canada |
2770557 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
China |
ZL201080035390.6 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Czech Republic |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Denmark |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Eurasian Patent Office |
032045 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Finland |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
France |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Germany |
60 2009 010 275.3 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Hong Kong |
1167677 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
India |
337600 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Ireland |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Italy |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Japan |
5794985 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Korea - South |
10-1877286 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Mexico |
317816 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Netherlands |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Norway |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Poland |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Russia |
032045 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Singapore |
178292 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
South Africa |
2012/00627 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Spain |
2394668 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Sweden |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Switzerland |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Taiwan |
I 450965 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
Türkiye |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United Kingdom |
2284273 |
| Vector Comprising Mannoses Promoter and Mannose Promoter |
XS Technologies® - Microbial Biopharmaceutical Services |
United States |
9163247 |
| Methods for Nuclear Reprogramming Using Synthetic Transcription Factors |
Cell and Gene Therapies |
Israel |
255536 |